Adjusted regression coefficients (β) of CCL13, CCL11, and CCL26 levels with relapse times, ARR, and EDSS scores as outcomes in neuromyelitis optica spectrum disorder patients. This evidence concerns the gene CCL13 and neuromyelitis optica.